Simplifying the treatment of acute bacterial bone and joint infections in children

Expert Rev Anti Infect Ther. 2011 Dec;9(12):1125-31. doi: 10.1586/eri.11.140.

Abstract

The treatment of acute hematogenous bone and joint infections of children - osteomyelitis (OM), septic arthritis (SA) and OM-SA combination (OM+SA) - has simplified over the past years. The old approach included months-long antibiotic treatment, started intravenously for at least a week, followed by oral completion of the course. Recent prospective randomized trials show that most cases heal with a total course of 3 weeks (OM, OM+SA) or 2 weeks (SA) of an appropriate antibiotic, provided the clinical response is good and C-reactive protein level has normalized. If the prevalence of methicillin-resistant Staphylococcus aureus and Kingella kingae is low, clindamycin and a first-generation cephalosporin are safe, inexpensive and effective alternatives. They should be administered in large doses and four times a day. Clindamycin, vancomycin and expensive linezolid are options against methicillin-resistant Staphylococcus aureus. Extensive surgery beyond a diagnostic sample by aspiration is rarely needed in uncomplicated cases.

Publication types

  • Review

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / therapeutic use
  • Acute Disease
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious / complications
  • Arthritis, Infectious / diagnosis
  • Arthritis, Infectious / drug therapy*
  • Arthritis, Infectious / microbiology
  • Bone and Bones
  • C-Reactive Protein / analysis
  • Child
  • Child, Preschool
  • Clindamycin / administration & dosage
  • Clindamycin / therapeutic use
  • Drug Administration Schedule
  • Finland
  • Humans
  • Joints
  • Kingella kingae / drug effects*
  • Kingella kingae / growth & development
  • Linezolid
  • Methicillin Resistance / drug effects
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Neisseriaceae Infections / complications
  • Neisseriaceae Infections / diagnosis
  • Neisseriaceae Infections / drug therapy*
  • Neisseriaceae Infections / microbiology
  • Osteomyelitis / complications
  • Osteomyelitis / diagnosis
  • Osteomyelitis / drug therapy*
  • Osteomyelitis / microbiology
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / therapeutic use
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Vancomycin / administration & dosage
  • Vancomycin / therapeutic use

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Clindamycin
  • Vancomycin
  • C-Reactive Protein
  • Linezolid